A cancer drug sold by GlaxoSmithKline was shown in a clinical trial to extend by several months the length of time ovarian cancer patients lived without their disease worsening.
Lung cancer patients who received a drug designed to target a genetic dysfunction lived longer with fewer side effects than those who received traditional chemotherapy, a study showed Saturday.
New hope for the treatment of melanoma and colorectal cancer was presented at a major cancer research conference in Chicago Saturday.
Russia's ambitious smoking ban, which aims to cut the number of smokers in half and improve public health, went into effect Saturday amid doubts that its measures can be fully enforced.
A Japanese cancer specialist said Wednesday she has started the world's first clinical trial of a powerful, nonsurgical, short-term radiation therapy for breast cancer.
A draft amendment was passed by the Cabinet yesterday that would hike the tobacco tax and the Health and Welfare Surcharge, raising the price of a pack of cigarettes by NT$25.
A new genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it.
Stepping into the debate over who should be screened for lung cancer, a leading medical specialty group issued new guidelines on Tuesday recommending that doctors offer annual low-dose CT (computed tomography) scanning to people whose age and smoking history puts them at significant risk of lung cancer.
To further raise cancer awareness and promote preventative screening among women, Procter & Gamble (P&G) announced at a press event yesterday that its “6 Minutes Protect A Life” campaign will take place throughout the month.
Some of the most devastating forms of cancer have genetic similarities even though they strike different body parts, according to new studies out Thursday.